Brain Imaging of Intranasal Oxytocin Treatment in Autism
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This is a 4 part study:
Phase 1a. -functional magnetic resonance imaging (fMRI) ( with oxytocin 24 IU vs. placebo =
oxytocin 0 IU) - funded by grant #U54 HD079124-01, Phase 1b-eye-tracking(oxytocin 24 IU vs.
placebo = oxytocin 0 IU), Phase 2a. fMRI (oxytocin 8 IU vs. oxytocin 40IU), Phase 2b.
-eye-tracking (oxytocin 8IU vs. oxytocin 40IU). Time course of effect will also be assessed
within session.
Phase:
Phase 1
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborators:
Duke University Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)